Healthy Returns: Novavax scores narrower Covid vaccine approval after delay – CNBC

by | May 20, 2025 | COVID-19

Healthy Returns: Novavax scores narrower Covid vaccine approval after delay  CNBCAfter delay, FDA approves Novavax’s Covid-19 vaccine, but only for older people and those at high risk  CNNStatement on the antigen composition of COVID-19 vaccines  World Health Organization (WHO)Novavax shares jump after long-awaited FDA approval of its COVID-19 vaccine  ReutersNovavax Stock Rockets. FDA Finally Had Good News for the Covid-19 Vaccine Maker.  Barron’sNovavax climbs after its Covid jab gets FDA approval  Sherwood NewsFDA approves Novavax COVID-19 shot but with unusual restrictions  YahooFDA approves Novavax’s COVID-19 vaccine — with restrictions  HealioFDA Grants Full Approval to Novavax’s Nuvaxovid COVID-19 Vaccine  Pharmaceutical Executive

Article Attribution | Read More at Article Source